(Q43714765)

26 November 2017

An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy (English)

1 reference

26 November 2017

1 reference

1 reference

1 reference

6

Targan SR

1 reference

26 November 2017

Dubinsky MC

1

1 reference

26 November 2017

Hassard PV

2

1 reference

26 November 2017

Seidman EG

3

1 reference

26 November 2017

Kam LY

4

1 reference

26 November 2017

Abreu MT

5

1 reference

26 November 2017

Vasiliauskas EA

7

1 reference

26 November 2017

1 August 2001

1 reference

Inflammatory Bowel Diseases

26 November 2017

1 reference

26 November 2017

7

1 reference

26 November 2017

3

1 reference

26 November 2017

181-189

1 reference

A controlled double blind study of azathioprine in the management of Crohn's disease

26 November 2017

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200108000-00001

Randomised controlled trial of azathioprine withdrawal in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200108000-00001

Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200108000-00001

The clinical pharmacology of 6-mercaptopurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200108000-00001

Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200108000-00001

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200108000-00001

Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200108000-00001

Thioguanine versus mercaptopurine for therapy of childhood lymphoblastic leukaemia: a comparison of haematological toxicity and drug metabolite concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200108000-00001

Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200108000-00001

Resistance to 6-thioguanine in mismatch repair-deficient human cancer cell lines correlates with an increase in induced mutations at the HPRT locus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200108000-00001

Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200108000-00001

Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200108000-00001

10.1097/00054725-200108000-00001

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference